Wöll E - Search Results

1

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.

Wöll E, Thaler J, Keil F, Gruenberger B, Hejna M, Eisterer W, Fridrik MA, Ulmer H, Trommet V, Huemer F, Weiss L, Greil R. Wöll E, et al. Anticancer Res. 2017 Oct;37(10):5553-5558. doi: 10.21873/anticanres.11987. Anticancer Res. 2017. PMID: 28982869 Clinical Trial.

2

Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.

Lhotta K, Kühr T, Rumpelt HJ, Wöll E, Thaler J, König P. Lhotta K, et al. Among authors: woll e. Am J Nephrol. 1999;19(5):590-3. doi: 10.1159/000013525. Am J Nephrol. 1999. PMID: 10575189

3

Comparison of automated cellular imaging system and manual microscopy for immunohistochemically stained cryostat sections of lung cancer specimens applying p53, ki-67 and p120.

Hilbe W, Gächter A, Duba HC, Dirnhofer S, Eisterer W, Schmid T, Mildner A, Bodner J, Wöll E. Hilbe W, et al. Among authors: woll e. Oncol Rep. 2003 Jan-Feb;10(1):15-20. Oncol Rep. 2003. PMID: 12469137 Review.

4

Characterisation and predictive value of epidermal growth factor receptor status using quantitative real-time PCR combined with immunohistochemistry on non-small cell lung cancer specimens.

Hilbe W, Dlaska M, Dirnhofer S, Duba HC, Eisterer W, Oberwasserlechner F, Mildner A, Schmid T, Ammann K, Thaler J, Wöll E. Hilbe W, et al. Among authors: woll e. Int J Oncol. 2003 Oct;23(4):893-9. Int J Oncol. 2003. PMID: 12963967

5

Automated real-time PCR to determine K-ras codon 12 mutations in non-small cell lung cancer: comparison with immunohistochemistry and clinico-pathological features.

Hilbe W, Dlaska M, Duba HC, Dirnhofer S, Eisterer W, Oberwasserlechner F, Mildner A, Schmid T, Kühr T, Wöll E. Hilbe W, et al. Among authors: woll e. Int J Oncol. 2003 Oct;23(4):1121-6. Int J Oncol. 2003. PMID: 12963994

6

Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.

Hilbe W, Dirnhofer S, Oberwasserlechner F, Eisterer W, Ammann K, Schmid T, Hilbe G, Thaler J, Wöll E. Hilbe W, et al. Among authors: woll e. J Clin Pathol. 2003 Oct;56(10):736-41. doi: 10.1136/jcp.56.10.736. J Clin Pathol. 2003. PMID: 14514775 Free PMC article.

7

Biomarkers in non-small cell lung cancer prevention.

Hilbe W, Dirnhofer S, Greil R, Wöll E. Hilbe W, et al. Among authors: woll e. Eur J Cancer Prev. 2004 Oct;13(5):425-36. doi: 10.1097/00008469-200410000-00011. Eur J Cancer Prev. 2004. PMID: 15452456 Review.

8

Chemotherapy in gastric cancer.

Wöll E, Devries A, Eisterer W, Hejna M, Keil F, Stein H, Zacherl J, Greil R. Wöll E, et al. Anticancer Res. 2008 Mar-Apr;28(2B):1213-9. Anticancer Res. 2008. PMID: 18505058 Free article. Review.

9

Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT).

Wöll E, Kühr T, Eisterer W, Gattringer K, Greil R, Zabernigg A, Hilbe W, Thaler J. Wöll E, et al. Anticancer Res. 2008 Sep-Oct;28(5B):2901-5. Anticancer Res. 2008. PMID: 19031932 Free article. Clinical Trial.

10

Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.

Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M, Kapp KS, Fastner G, Keil F, Eisterer W, Jäger R, Offner F, Gnant M, Thaler J; TAKO 05/ABCSG R-02 Trial Investigators. Ofner D, et al. Strahlenther Onkol. 2011 Feb;187(2):100-7. doi: 10.1007/s00066-010-2182-6. Epub 2011 Jan 21. Strahlenther Onkol. 2011. PMID: 21267531 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page